Advanced Medical Isotope PE Ratio 2013-2025 | RDGL
Current and historical p/e ratio for Advanced Medical Isotope (RDGL) from 2013 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Advanced Medical Isotope PE ratio as of January 22, 2026 is 0.00.
| Advanced Medical Isotope PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-01-23 | 0.07 | 0.00 | |
| 2025-09-30 | 0.09 | 0 | 0.00 |
| 2025-06-30 | 0.11 | 0 | 0.00 |
| 2025-03-31 | 0.12 | 0 | 0.00 |
| 2024-12-31 | 0.11 | 0 | 0.00 |
| 2024-09-30 | 0.16 | $-0.01 | 0.00 |
| 2024-06-30 | 0.20 | $-0.01 | 0.00 |
| 2024-03-31 | 0.07 | $-0.01 | 0.00 |
| 2023-12-31 | 0.07 | $-0.01 | 0.00 |
| 2023-09-30 | 0.07 | 0 | 0.00 |
| 2023-06-30 | 0.05 | 0 | 0.00 |
| 2023-03-31 | 0.07 | 0 | 0.00 |
| 2022-12-31 | 0.04 | 0 | 0.00 |
| 2022-09-30 | 0.05 | 0 | 0.00 |
| 2022-06-30 | 0.07 | 0 | 0.00 |
| 2022-03-31 | 0.07 | $-0.01 | 0.00 |
| 2021-12-31 | 0.08 | $-0.01 | 0.00 |
| 2021-09-30 | 0.12 | $-0.01 | 0.00 |
| 2021-06-30 | 0.12 | $-0.01 | 0.00 |
| 2021-03-31 | 0.10 | 0 | 0.00 |
| 2020-12-31 | 0.11 | 0 | 0.00 |
| 2020-09-30 | 0.03 | 0 | 0.00 |
| 2020-06-30 | 0.04 | 0 | 0.00 |
| 2020-03-31 | 0.03 | 0 | 0.00 |
| 2019-12-31 | 0.04 | 0 | 0.00 |
| 2019-09-30 | 0.04 | 0 | 0.00 |
| 2019-06-30 | 0.03 | 0 | 0.00 |
| 2019-03-31 | 0.02 | $-0.56 | 0.00 |
| 2018-12-31 | 0.06 | $-0.64 | 0.00 |
| 2018-09-30 | 0.14 | $-0.64 | 0.00 |
| 2018-06-30 | 0.02 | $-0.64 | 0.00 |
| 2018-03-31 | 0.24 | $-0.32 | 0.00 |
| 2017-12-31 | 0.40 | $-0.32 | 0.00 |
| 2017-09-30 | 0.57 | $0.08 | 7.07 |
| 2017-06-30 | 0.66 | 0 | 0.00 |
| 2017-03-31 | 1.21 | $0.24 | 5.03 |
| 2016-12-31 | 1.40 | $0.32 | 4.37 |
| 2016-09-30 | 1.68 | $-0.08 | 0.00 |
| 2016-06-30 | 2.96 | 0 | 0.00 |
| 2016-03-31 | 3.76 | 0 | 0.00 |
| 2015-12-31 | 1.84 | 0 | 0.00 |
| 2015-09-30 | 1.12 | 0 | 0.00 |
| 2015-06-30 | 0.72 | 0 | 0.00 |
| 2015-03-31 | 2.80 | 0 | 0.00 |
| 2014-12-31 | 0.72 | 0 | 0.00 |
| 2014-09-30 | 2.88 | 0 | 0.00 |
| 2014-06-30 | 17.52 | 0 | 0.00 |
| 2014-03-31 | 39.84 | 0 | 0.00 |
| 2013-12-31 | 50.40 | 0 | 0.00 |
| 2013-09-30 | 38.40 | 0 | 0.00 |
| 2013-06-30 | 48.00 | 0 | 0.00 |
| 2013-03-31 | 100.80 | 0 | 0.00 |
| 2012-12-31 | 148.00 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Finance | Finance - SBIC & Commercial | $0.030B | $0.000B |
| Vivos Inc. is a late stage development company. It engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos Inc., formerly known as Advanced Medical Isotope Corporation, is based in Richland, Washington. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ares Capital (ARCC) | United States | $14.959B | 10.19 |
| Blue Owl Technology Finance (OTF) | United States | $6.551B | 9.32 |
| Blackstone Secured Lending Fund (BXSL) | United States | $6.171B | 8.19 |
| Main Street Capital (MAIN) | United States | $5.749B | 16.08 |
| Golub Capital BDC (GBDC) | United States | $3.604B | 8.77 |
| Hercules Capital (HTGC) | United States | $3.411B | 9.73 |
| Sixth Street Specialty Lending (TSLX) | United States | $2.103B | 9.76 |
| Morgan Stanley Direct Lending Fund (MSDL) | United States | $1.437B | 7.92 |
| Trinity Capital (TRIN) | United States | $1.265B | 7.85 |
| Amalgamated Financial (AMAL) | United States | $1.151B | 10.50 |
| Goldman Sachs BDC (GSBD) | United States | $1.073B | 5.66 |
| Kayne Anderson BDC (KBDC) | United States | $1.003B | 8.57 |
| BARINGS BDC, INC (BBDC) | United States | $0.971B | 8.17 |
| New Mountain Finance (NMFC) | United States | $0.943B | 7.14 |
| Bain Capital Specialty Finance (BCSF) | United States | $0.889B | 7.07 |
| Fidus Investment (FDUS) | United States | $0.717B | 9.16 |
| Nuveen Churchill Direct Lending (NCDL) | United States | $0.672B | 6.87 |
| Carlyle Secured Lending (CGBD) | United States | $0.656B | 7.80 |
| Gladstone Investment (GAIN) | United States | $0.551B | 14.32 |
| Crescent Capital BDC (CCAP) | United States | $0.539B | 7.58 |
| BLACKROCK TCP CAPITAL CORP (TCPC) | United States | $0.500B | 4.27 |
| CION Investment (CION) | United States | $0.489B | 5.30 |
| Gladstone Capital (GLAD) | United States | $0.476B | 10.44 |
| PennantPark Investment (PNNT) | United States | $0.390B | 8.41 |
| Saratoga Investment Corp (SAR) | United States | $0.379B | 9.71 |
| Stellus Capital Investment (SCM) | United States | $0.377B | 9.10 |
| Palmer Square Capital BDC (PSBD) | United States | $0.375B | 6.92 |
| Runway Growth Finance (RWAY) | United States | $0.340B | 5.81 |
| Horizon Technology Finance (HRZN) | United States | $0.310B | 5.92 |
| TriplePoint Venture Growth BDC (TPVG) | United States | $0.263B | 5.75 |
| Chicago Atlantic BDC (LIEN) | United States | $0.240B | 13.64 |
| Medallion Financial (MFIN) | United States | $0.239B | 5.55 |
| WhiteHorse Finance (WHF) | United States | $0.162B | 5.97 |
| Oxford Square Capital (OXSQ) | United States | $0.152B | 5.64 |
| PhenixFIN (PFX) | United States | $0.087B | 17.06 |
| Investcorp Credit Management BDC (ICMB) | United States | $0.040B | 16.32 |
| Rand Capital (RAND) | United States | $0.034B | 7.60 |
| SLR Investment (SLRC) | United States | $0.000B | 9.27 |
| OFS Capital (OFS) | United States | $0.000B | 4.93 |
| FS KKR Capital (FSK) | United States | $0.000B | 11.30 |